Abiomed Inc (ABMD)
$255.83 0.64 (0.25%)
15:18 EDT ABMD Stock Quote Delayed 15 Minutes
Previous Close $256.47
Market Cap 11.38B
PE Ratio 104.42
Volume (Avg. Vol.) 360,004
Day's Range 252.57 - 258.39
52-Week Range 228.00 - 459.75
Dividend & Yield N/A (N/A)
ABMD Stock Predictions, Articles, and Abiomed Inc News
- From InvestorPlace
- From the Web
These beaten-down healthcare stocks still have plenty of long-term potential. Here's what investors need to know about each.
Forget Amazon.com. Here are eight stocks to buy with better, and more proven, growth track records and growth prospects.
Not all stocks lost out in 2018. These are the strong-buy stocks that emerged victorious from a year of extremely volatile trading.
The markets may be volatile but the trends for these tech stocks are strong.
As we move toward the start of a new year, the best stocks are not only showing their strength now, but can carry it forward. These 10 make the list!
October has been volatile, but some stocks offer safety from the storm. Whether you’re just starting out or an investing veteran, these are core stocks to buy.
These are the 10 best stocks to buy now. Regardless of market conditions, they should continue to climb for years to come.
Medical device stocks could be the best play in all of healthcare. Here are five of the best choices for any portfolio.
Niche medical device maker Abiomed has plenty of heart for growth. ABMD stock isn't the sexiest play, but it's well worth a look.
Abiomed stock is down 10 percent following first-quarter earnings. The company exceeded expectations and reported growth in the triple digits. So what gives? The good news is priced in.
If you're looking for some stellar stocks to buy, these 7 A-rated stocks are worth a look from any investor.
It may be all about taxes now, but 2018 is all about healthcare. The following are some of the best healthcare stocks to buy in 2018.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!